During the past decade, Ospedale Regionale Generale- Divisione Ematologia conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 4 clinical trials were completed, i.e. on average, 57.1% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 3 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ospedale Regionale Generale- Divisione Ematologia" #1 collaborator was "Azienda Policlinico Umberto I" with 1 trials as a collaborator, "Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia" with 1 trials as a collaborator, "Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte" with 1 trials as a collaborator and "Study Alliance Leukemia (SAL) Group" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Ospedale Regionale Generale- Divisione Ematologia" are "Acute Promyelocytic Leukemia" (2 trials), "Hematologic Diseases" (2 trials), "Non-Hodgkin's Lymphoma" (2 trials), "Stem Cell Transplant Complications" (2 trials) and "ALL, Adult" (1 trials). Many other conditions were trialed in "Ospedale Regionale Generale- Divisione Ematologia" in a lesser frequency.

Most popular intervention types in "Ospedale Regionale Generale- Divisione Ematologia" are "Drug" (11 trials), "Other" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Adrenomedullin" (1 trials), "Bendamustine" (1 trials), "Busulphan plus Cyclophosphamide" (1 trials), "Busulphan plus Fludarabine" (1 trials) and "Chemotherapy (Induction Period)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ospedale Regionale Generale- Divisione Ematologia" are 17 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Ospedale Regionale Generale- Divisione Ematologia". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Ospedale Regionale Generale- Divisione Ematologia, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ospedale Regionale Generale- Divisione Ematologia, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".